Małgorzata Żendzian-Piotrowska Selected Research

Adenoma (Adenomas)

1/2021	Antioxidant Barrier and Oxidative Damage to Proteins, Lipids, and DNA/RNA in Adrenal Tumor Patients.
4/2015	Sphingolipid metabolism in colorectal adenomas varies depending on histological architecture of polyps and grade of nuclear dysplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Małgorzata Żendzian-Piotrowska Research Topics

Disease

12	Insulin Resistance 09/2022 - 01/2015
7	Inflammation (Inflammations) 01/2023 - 03/2017
5	Pancreatitis 01/2022 - 12/2017
5	Obesity 05/2020 - 01/2016
4	Neoplasms (Cancer) 01/2021 - 04/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 09/2013
3	Morbid Obesity 11/2020 - 07/2016
3	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2020 - 03/2017
3	Type 2 Diabetes Mellitus (MODY) 10/2018 - 01/2015
2	Chronic Renal Insufficiency 12/2023 - 01/2023
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 09/2023 - 03/2017
2	COVID-19 01/2023 - 01/2023
2	Respiratory Insufficiency (Respiratory Failure) 01/2023 - 01/2023
2	Pneumonia (Pneumonitis) 01/2023 - 01/2023
2	Diabetes Mellitus 09/2022 - 01/2020
2	Adenoma (Adenomas) 01/2021 - 04/2015
2	Body Weight (Weight, Body) 01/2021 - 01/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2020 - 05/2020
2	Weight Loss (Weight Reduction) 05/2020 - 09/2019
1	Hypersensitivity (Allergy) 04/2024
1	Parkinson Disease (Parkinson's Disease) 12/2023
1	Cognitive Dysfunction 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Hypertension (High Blood Pressure) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Pheochromocytoma 01/2021
1	Heart Failure 01/2021
1	Pathologic Processes 01/2020

Drug/Important Bio-Agent (IBA)

12	SphingolipidsIBA 09/2022 - 09/2013
9	AntioxidantsIBA 01/2022 - 07/2016
7	CeramidesIBA 09/2022 - 09/2013
6	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
6	LipidsIBA 01/2021 - 01/2015
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 11/2020
4	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 03/2017
4	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022 - 04/2015
3	CytokinesIBA 01/2023 - 01/2023
3	Insulin (Novolin)FDA Link 01/2022 - 01/2021
3	Acetylcysteine (Siran)FDA LinkGeneric 02/2020 - 01/2018
3	SphingomyelinsIBA 01/2018 - 09/2013
3	Streptozocin (Streptozotocin)FDA Link 10/2017 - 11/2016
2	ischemia-modified albuminIBA 12/2023 - 01/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023 - 01/2023
2	ChemokinesIBA 01/2023 - 01/2023
2	Thioctic Acid (Lipoic Acid)IBA 01/2022 - 01/2022
2	3-nitrotyrosineIBA 01/2021 - 01/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2021
2	Peroxidase (Myeloperoxidase)IBA 01/2021 - 07/2016
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 01/2019
2	Advanced Glycation End ProductsIBA 01/2021 - 07/2016
2	Peroxynitrous Acid (Peroxynitrite)IBA 01/2021 - 01/2019
2	Oxidants (Oxidizing Agents)IBA 05/2020 - 07/2016
2	Free RadicalsIBA 02/2020 - 01/2019
2	CeruletideIBA 01/2019 - 01/2018
2	Malondialdehyde (Propanedial)IBA 01/2019 - 07/2016
2	SphingosineIBA 12/2017 - 09/2013
2	thermozymocidin (myriocin)IBA 03/2017 - 01/2015
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 04/2024
1	Amantadine (Aman)FDA LinkGeneric 12/2023
1	Histamine H2 AntagonistsIBA 09/2023
1	Verapamil (Calan)FDA LinkGeneric 01/2023
1	Becaplermin (PDGF-BB)FDA Link 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	Interleukin-18 (Interleukin 18)IBA 01/2023
1	Interleukin-16 (Interleukin 16)IBA 01/2023
1	Chemokine CCL5IBA 01/2023
1	Interleukin-12 (IL 12)IBA 01/2023
1	Interleukin-9 (Interleukin 9)IBA 01/2023
1	Interleukin-8 (Interleukin 8)IBA 01/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023
1	Macrophage Colony-Stimulating FactorIBA 01/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	GelsolinIBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	EnzymesIBA 01/2022
1	AlbuminsIBA 10/2021
1	PhloroglucinolIBA 10/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Sulfhydryl Compounds (Thiols)IBA 01/2021
1	Valsartan (Vals)FDA Link 01/2021
1	N 30IBA 01/2021
1	LeptinIBA 01/2021
1	dityrosineIBA 01/2021
1	KynurenineIBA 01/2021
1	N'-formylkynurenineIBA 01/2021
1	Angiotensin IIIBA 01/2021
1	AdipokinesIBA 01/2021
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2021
1	Tryptophan (L-Tryptophan)FDA Link 01/2021
1	ResistinIBA 01/2021
1	Glutathione (Reduced Glutathione)IBA 02/2020

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 09/2022
1	Gastrectomy 09/2019